03.14.12
Slovenia-based Vitiva has entered a new collaboration with Israel-based biotech company Naturamed based on an exclusive agreement to manufacture Naturamed Ltd.'s product line at Vitiva's facilities and market the line to the U.S. and Europe via Vitiva ‘s distribution channels.
Ohad Cohen, CEO of Vitiva said the goal of the partnership will be to develop innovative, yet traditional supplements for assisting in the relief of acute health problems. “The population of developed countries, including the West and Japan, is getting older while healthcare costs are increasing year by year. The older population raises the demand for effective natural solutions for specific health conditions. Our goal is to offer the consumer natural remedies, backed by scientific research, for improving health.”
Naturamed is a biotech company that develops unique compounds extracted from specific strains of plant materials for improved natural treatment solutions. The company focuses especially on products directed toward ameliorating benign prostatic hyperplasia (BPH).
Ohad Cohen, CEO of Vitiva said the goal of the partnership will be to develop innovative, yet traditional supplements for assisting in the relief of acute health problems. “The population of developed countries, including the West and Japan, is getting older while healthcare costs are increasing year by year. The older population raises the demand for effective natural solutions for specific health conditions. Our goal is to offer the consumer natural remedies, backed by scientific research, for improving health.”
Naturamed is a biotech company that develops unique compounds extracted from specific strains of plant materials for improved natural treatment solutions. The company focuses especially on products directed toward ameliorating benign prostatic hyperplasia (BPH).